The olfactory bulb (OB) shows early neuropathological hallmarks in numerous neurodegenerative diseases, for example, in Alzheimer’s disease (AD) and Parkinson’s disease (PD). The glomerular and granular cell layer of the OB is characterized by preserved cellular plasticity in the adult brain. In turn, alterations of this cellular plasticity are related to neuroinflammation such as microglia activation, implicated in the pathogenesis of AD and PD, as well as frontotemporal lobe degeneration (FTLD). To determine microglia proliferation and activation we analyzed ionized calcium binding adaptor molecule 1 (Iba1) expressing microglia in the glomerular and granular cell layer, and the olfactory tract of the OB from patients with AD, PD dementia/...
The sense of smell has been shown to deteriorate in patients with some neurodegenerative disorders. ...
Aims: Microglia-driven neuroinflammation can play an important role in the pathophysiology of neurod...
Synucleinopathies (including α-synucleinopathies), which include Parkinson’s disease (PD), manifest ...
The olfactory bulb (OB) shows early neuropathological hallmarks in numerous neurodegenerative diseas...
The olfactory bulb (OB) is affected early in both Parkinson's (PD) and Alzheimer's disease (AD), evi...
The olfactory bulb (OB) is affected early in both Parkinson's (PD) and Alzheimer's disease (AD), evi...
AbstractProgressive olfactory impairment is one of the earliest markers of neurodegeneration. Howeve...
Alzheimer's disease (AD) is the most prevalent form of dementia. Key AD symptoms include memory and ...
Olfactory dysfunction is among the earliest features of Alzheimer's disease (AD). Although neuropath...
BACKGROUND: In Alzheimer's disease (AD) the olfactory system, including the olfactory bulb, a limbic...
Mild olfactory dysfunction has been observed in frontotemporal dementias (FTD). However, the underly...
Immunolocalization of apolipoprotein Ε (apoE) was investigated in human olfactory mucosa in which ol...
The most common form of mixed dementia (MixD) is constituted by abnormal protein deposits associated...
Olfactory dysfunction is considered an early prodromal marker of many neurodegenerative diseases. Ne...
Olfactory capacity declines with aging, but increasing evidence shows that smell dysfunction is one ...
The sense of smell has been shown to deteriorate in patients with some neurodegenerative disorders. ...
Aims: Microglia-driven neuroinflammation can play an important role in the pathophysiology of neurod...
Synucleinopathies (including α-synucleinopathies), which include Parkinson’s disease (PD), manifest ...
The olfactory bulb (OB) shows early neuropathological hallmarks in numerous neurodegenerative diseas...
The olfactory bulb (OB) is affected early in both Parkinson's (PD) and Alzheimer's disease (AD), evi...
The olfactory bulb (OB) is affected early in both Parkinson's (PD) and Alzheimer's disease (AD), evi...
AbstractProgressive olfactory impairment is one of the earliest markers of neurodegeneration. Howeve...
Alzheimer's disease (AD) is the most prevalent form of dementia. Key AD symptoms include memory and ...
Olfactory dysfunction is among the earliest features of Alzheimer's disease (AD). Although neuropath...
BACKGROUND: In Alzheimer's disease (AD) the olfactory system, including the olfactory bulb, a limbic...
Mild olfactory dysfunction has been observed in frontotemporal dementias (FTD). However, the underly...
Immunolocalization of apolipoprotein Ε (apoE) was investigated in human olfactory mucosa in which ol...
The most common form of mixed dementia (MixD) is constituted by abnormal protein deposits associated...
Olfactory dysfunction is considered an early prodromal marker of many neurodegenerative diseases. Ne...
Olfactory capacity declines with aging, but increasing evidence shows that smell dysfunction is one ...
The sense of smell has been shown to deteriorate in patients with some neurodegenerative disorders. ...
Aims: Microglia-driven neuroinflammation can play an important role in the pathophysiology of neurod...
Synucleinopathies (including α-synucleinopathies), which include Parkinson’s disease (PD), manifest ...